Patent Assignment
Reel/Frame 050629/0820
Assignment of Assignor's Interest
Recorded: 2019-10-04
Pages: 5
Assignor
CLEARSIDE BIOMEDICAL, INC.
Executed: 2019-09-09
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Plasma Kallikrein Inhibitors and Methods of Use Thereof in Ocular Disorders
Application:
62/830,802 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 22, 2019
From: KANSARA, VIRAL; MCELHENY, RICK
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 049256/0250 →
Security Interest
Aug 29, 2019
From: CLEARSIDE BIOMEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 050217/0270 →
Release of Security Interest
Jul 7, 2020
From: SILICON VALLEY BANK
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 053139/0929 →
Assignment of Assignor's Interest
Oct 6, 2021
From: CLEARSIDE BIOMEDICAL, INC
To: BYOCRYST PHARMACEUTICALS, INC
Reel/Frame 057714/0512 →
Assignment of Assignor's Interest
Dec 29, 2025
From: BABU, YARLAGADDA S.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0321 →